Metabonomics Fingerprinting of Multiple Trauma
Establishing 1H Nuclear Magnetic Resonance (NMR) Based Metabonomics Fingerprinting Profile for Severe Poly Trauma Patients
1 other identifier
observational
40
1 country
1
Brief Summary
The aim of this study is to establish plasma metabonomics fingerprinting atlas for severe multiple trauma patient using 1H nuclear magnetic resonance (NMR) based metabonomics methodology and advanced mathematics tools.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 14, 2011
CompletedFirst Posted
Study publicly available on registry
January 19, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedJuly 27, 2011
July 1, 2011
1 year
January 14, 2011
July 26, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality at hospitalization
Death events from admission to discharge(up to 10 weeks)
Secondary Outcomes (1)
Multi Organ Failure(MOF)
MOF events occurence from admission to discharge(up to 10 weeks)
Study Arms (2)
Poly trauma
20 Patients suffering from poly trauma who meet inclusion criteria would be recruited
Healthy control
20 healthy volunteers would be recruited to obtain basal metabonomics fingerprinting
Eligibility Criteria
Patients who are suffering from poly trauma.
You may qualify if:
- Age:18-50 years
- Poly trauma
- Injury Severity Score (ISS)\>16 and Acute Physiology And Chronic Health Evaluation(APACHE)II\>10
You may not qualify if:
- With comorbidity (Diabetes,Hyperthyroidism or primary organ dysfunction )
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sichuan Academy of Medical Sciences, Sichuan Provincial Hospital, Dept. Trauma Surgery
Chengdu, Sichuan, 610101, China
Biospecimen
Plasma from peripheral blood.
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Hua Jiang, M.D
Sichuan Academy of Medical Sciences
- PRINCIPAL INVESTIGATOR
Zhi-Yuan Zhou, M.S
Sichuan Academy of Medical Sciences
- PRINCIPAL INVESTIGATOR
Ming-Wei Sun, M.D
Sichuan Academy of Medical Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 14, 2011
First Posted
January 19, 2011
Study Start
June 1, 2010
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
July 27, 2011
Record last verified: 2011-07